Skip to menu Skip to content Skip to footer

Innovations in peptide-based drug design (2011-2014)

Abstract

The overall aim of this project is to develop innovative generic strategies to facilitate the development of peptides as new drugs. Peptides are naturally occurring sequences of amino acids, and are the most abundant organic molecules in cells, with fundamental roles in defining life, ageing, disease and death in all organisms. They therefore are regarded as important drug leads, but because synthetic peptides have limited stability and bioavailability this promise has so far not been realised. In this project we aim to overcome these major limitations, by developing strategies to stabilise peptides, and then applying the findings to selected targets to demonstrate how peptides can become the next generation of pharmaceuticals.

Experts

Professor David Craik

UQ Laureate Fellow - GL
Institute for Molecular Bioscience
Centre Director of ARC COE for Inno
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
Affiliate Professor of School of Bi
School of Biomedical Sciences
Faculty of Medicine
David Craik
David Craik

Professor David Fairlie

Affiliate of ARC COE for Innovation
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
of Institute for Molecular Bioscien
Institute for Molecular Bioscience
NHMRC Leadership Fellow and Group L
Institute for Molecular Bioscience
David Fairlie
David Fairlie